DE68910444T2 - 2-(1-Pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl)-Thiazol-Hemiphosphat-Hemihydrat. - Google Patents

2-(1-Pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl)-Thiazol-Hemiphosphat-Hemihydrat.

Info

Publication number
DE68910444T2
DE68910444T2 DE89308480T DE68910444T DE68910444T2 DE 68910444 T2 DE68910444 T2 DE 68910444T2 DE 89308480 T DE89308480 T DE 89308480T DE 68910444 T DE68910444 T DE 68910444T DE 68910444 T2 DE68910444 T2 DE 68910444T2
Authority
DE
Germany
Prior art keywords
guanidino
imidazolyl
pentyl
thiazole
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE89308480T
Other languages
German (de)
English (en)
Other versions
DE68910444D1 (de
Inventor
Troy Anthony Appleton
Ward Marvin Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Original Assignee
Pfizer Corp Belgium
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium filed Critical Pfizer Corp Belgium
Application granted granted Critical
Publication of DE68910444D1 publication Critical patent/DE68910444D1/de
Publication of DE68910444T2 publication Critical patent/DE68910444T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Cephalosporin Compounds (AREA)
DE89308480T 1988-08-30 1989-08-22 2-(1-Pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl)-Thiazol-Hemiphosphat-Hemihydrat. Expired - Fee Related DE68910444T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1988/003019 WO1990002127A1 (en) 1988-08-30 1988-08-30 Hemiphosphate hemihydrate of 2-(1-pentyl-3-guanidino-4-imidazolyl)thiazole

Publications (2)

Publication Number Publication Date
DE68910444D1 DE68910444D1 (de) 1993-12-09
DE68910444T2 true DE68910444T2 (de) 1994-03-03

Family

ID=22208884

Family Applications (1)

Application Number Title Priority Date Filing Date
DE89308480T Expired - Fee Related DE68910444T2 (de) 1988-08-30 1989-08-22 2-(1-Pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl)-Thiazol-Hemiphosphat-Hemihydrat.

Country Status (11)

Country Link
EP (1) EP0357315B1 (enExample)
JP (1) JPH02108690A (enExample)
AT (1) ATE96794T1 (enExample)
CA (1) CA1320207C (enExample)
DE (1) DE68910444T2 (enExample)
DK (1) DK424189A (enExample)
ES (1) ES2059773T3 (enExample)
FI (1) FI94248C (enExample)
IE (1) IE61736B1 (enExample)
PT (1) PT91562B (enExample)
WO (1) WO1990002127A1 (enExample)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4621424A (en) * 1982-09-17 1986-11-11 The Gillette Company Razor blade assembly
US4560690A (en) * 1984-04-30 1985-12-24 Pfizer Inc. 2-(N-substituted guanidino)-4-hetero-arylthiazole antiulcer agents
US4632993A (en) * 1984-10-11 1986-12-30 Pfizer Inc. Process for making 2-guanidino-4-(2-methyl-4-imidazolyl) thiazole dihydrobromide
ES2054684T3 (es) * 1986-10-29 1994-08-16 Pfizer Procedimientos para la preparacion de 2-(1-pentil-3-guanidino)-4-(2-metil-4-imidazolil) tiazol y el dihidrocloruro trihidratado cristalino del mismo.

Also Published As

Publication number Publication date
DK424189A (da) 1990-03-01
EP0357315A3 (en) 1990-08-16
CA1320207C (en) 1993-07-13
WO1990002127A1 (en) 1990-03-08
PT91562B (pt) 1995-05-31
PT91562A (pt) 1990-03-30
EP0357315A2 (en) 1990-03-07
ATE96794T1 (de) 1993-11-15
JPH02108690A (ja) 1990-04-20
IE61736B1 (en) 1994-11-30
IE892765L (en) 1990-02-28
FI94248B (fi) 1995-04-28
ES2059773T3 (es) 1994-11-16
DE68910444D1 (de) 1993-12-09
JPH0456038B2 (enExample) 1992-09-07
FI94248C (fi) 1995-08-10
EP0357315B1 (en) 1993-11-03
DK424189D0 (da) 1989-08-29
FI910956A0 (fi) 1991-02-27

Similar Documents

Publication Publication Date Title
EP0780390B1 (de) Kristallmodifikation des CDCH, Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE60226044T2 (de) Kristalline formen von fluvastatin-natrium
WO1993010118A1 (de) Verfahren zur trennung von 5-methyl-tetrahydrofolsäure
DE2708192A1 (de) Kristalline alpha-form von 2- eckige klammer auf 4-(2-furoyl)-piperazin-1-yl eckige klammer zu -4-amino-6,7-dimethoxychinazolin-hydrochlorid und kristalline hydrate von 2- eckige klammer auf 4- (furoyl)-piperazin-1-yl eckige klammer zu -4-amino-6,7-dimethoxychinazolin-hydrochlorid, verfahren zur herstellung dieser kristallinen verbindungen und blutdrucksenkende mittel, die die kristallinen hydrate enthalten
DE2316920B2 (de) Benzo eckige klammer auf d eckige klammer zu eckige klammer auf 1,3 eckige klammer zu dioxolderivate, deren herstellung und diese enthaltende arzneimittel
DE60131416T2 (de) Chirale fluochinolon-argininsalzformen
DE69320875T2 (de) Fumarsäuresalze von Chinolinderivaten zur Aufhebung von vielfacher Drogenresistenz in der Krebsbehandlung
DE68910444T2 (de) 2-(1-Pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl)-Thiazol-Hemiphosphat-Hemihydrat.
DE2654647C2 (de) Kristallines Anhydrat von Natrium-7- (D-2-hydroxy-2-phenylacetamido)-3- (1-methyl-1H-tetrazol-5-ylthiomethyl) -3-cephem-4-carboxylat und Verfahren zu seiner Herstellung
DE60003679T2 (de) Polymorphe eines kristallinen azabicyclo(2,2,2) octan-3-amin citrat und diesen enthaltenden arzneimitteln
DE2060968A1 (de) Neue Thipyrane und Verfahren zu ihrer Herstellung
DE69025859T2 (de) Wasserfreie Kristalle von 4-Carbamoyl-1-beta-D-ribofuranosyl-imidazolium-5-Olat
DE4235133A1 (de) Kristallines (R)-(-)-2-Cycloheptyl-N-methylsulfonyl-[4-(2-chinolinyl-methoxy)-phenyl]-acetamid
DE2655130C3 (de) Eine praktisch lösungsmittelfreie Kristallform des Cefacetril-Natriumsalzes
DE2557033C2 (de) Acylderivate des 1,2-5,6-Dianhydro-dulcits, Verfahren zu deren Herstellung und diese Verbindungen enthaltende anticarcinogene Mittel
DE2407016A1 (de) 2-alkoxybenzoylaminosaeuren, verfahren zur herstellung derselben und antipyretisches mittel mit einem gehalt derselben
DE2316721A1 (de) Neue salze von biguaniden und verfahren zu ihrer herstellung
DE2657770A1 (de) In 8-stellung aminocarbonyl- und -sulfonylsubstituierte ergoline, ihre verwendung und herstellung
DE3104785A1 (de) Basische ether der 4-hydroxy-benzophenone, die als (beta)-blocker wirksam sind, und verfahren zu ihrer herstellung
DE69612626T2 (de) Hydrat-kristall und verfahren zu seiner herstellung
AT265530B (de) Verfahren zur Herstellung von neuen Isochinolinderivaten
AT282593B (de) Verfahren zur herstellung von neuem racemischem oder optisch aktivem (1-2'-nitrilophenoxy)-2-hydroxy-3-isopropylaminopropan und dessen salzen
AT220288B (de) Verfahren zur Herstellung von neuen therapeutisch wirksamen Estern des Erythromycins
AT258925B (de) Verfahren zur Herstellung von neuen Pyrimidinderivaten
DE1966641C3 (de) Verwendung von 4,4-Diarylpiperidinen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee